BRISTOL-MYERS SQUIBB’s PROHANCE NON-IONIC MRI CONTRAST AGENT APPROVED FOR CNS DISORDERS; SHIPPING BEGINS "IMMEDIATELY," UNIQUE DOSING OPTIONS STRESSED BY BMS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".